MUNDO
Anticuerpos sintéticos contra la covid-19. EE.UU empezó ensayos clínicos
La tercera fase del ensayo comenzará reclutando 300 voluntarios en todo el mundo entre pacientes hospitalizados que han presentado síntomas del virus entre leves y moderados.
5 de agosto de 2020
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/TXUIINRWHRA7NFCD5XMLNWUPW4.jpeg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/3XQI7ASNTRA53LJ7PMCLDU44JA.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/TFD6X5KPLJEVXOGECMDWWHNHNY.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/AYXD6FSOSRG7ZMBBATNBQJVZWA.png){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/NC2HF3YKYFAQJDITORVJPYSNHE.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/77KRFIQOBNB6ZPRPUO3AFVSWYM.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/R4NOGFGDHBBWFHQC2OJVFSDADE.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/3OXEH2Y75ZGEFDCH4AXOETU2JM.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/UM6FME5CEZE7ZJMSEVWSQSJTYM.jpg){kind=small}
:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/semana/HHEJAIMS7VDGHD46JYWQEG7UFI.jpg){kind=small}